Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-22

Clinical Trial Update: The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease

View source ↗

Summary

This clinical trial evaluating the effect of incretin hormones on endocrine pancreatic function during hyperglycemia in end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bo Feldt-Rasmussen | Conditions: End-stage Renal Disease | Status: COMPLETED